SCHEMBL2808703

SCHEMBL2808703

O=C(Nc1ccccc1)/C(=C/Sc1ccccc1)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.61
MAPT P10636 6/20 0.61
KMT2A Q03164 5/20 0.61
ALDH1A1 P00352 4/20 0.61
HTT P42858 4/20 0.61
MEN1 O00255 4/20 0.61
HPGD P15428 2/20 0.61
KDM4E B2RXH2 2/20 0.61
POLB P06746 1/20 0.61
MAPK1 P28482 1/20 0.61
SMN1; SMN2 Q16637 3/20 0.44
NPSR1 Q6W5P4 5/20 0.44
PLIN1 O60240 1/20 0.44
PLIN5 Q00G26 1/20 0.44
ABHD5 Q8WTS1 1/20 0.44
EPHX1 P07099 2/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
PLA2G1B P04054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2808706 1.00 LMNA (0.61) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2811204 0.84 HPGD (0.55) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2811206 0.84 HPGD (0.55) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2809793 0.81 NPC1 (0.51) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL3036930 0.81 NPC1 (0.51) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2809794 0.81 NPC1 (0.51) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2812831 0.79 HSD17B10 (0.53) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2812834 0.79 HSD17B10 (0.53) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2809786 0.79 KMT2A (0.42) LMNAMAPTKMT2AALDH1A1HTT
SCHEMBL2809789 0.79 KMT2A (0.42) LMNAMAPTKMT2AALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 LMNA 2201/4885MAPT 4608/4885KMT2A 3324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.